社区热敏灸治疗原发性高血压:含患者偏好臂的随机对照试验研究方案
本研究为多中心、实用性随机对照试验,设强制随机与患者偏好两个集群,计划纳入七个社区共400例原发性高血压患者,比较热敏灸联合原降压方案与单用原降压方案治疗6个月的效果。主要结局为收缩压自基线的变化,同时评估舒张压、降压药剂量、生活质量、症状严重程度、心血管事件、依从性、成本效果比及安全性。
要点
- 拟纳入七个社区400例原发性高血压患者,随访6个月、每月访视一次。
- 主要结局为收缩压自基线变化,次要结局含舒张压、降压药剂量、生活质量等。
- 试验设强制随机与患者偏好集群,可分析患者偏好效应并比较随机与非随机样本。
核心结论
- 该试验将为热敏灸作为基层医疗中原发性高血压治疗技术提供重要证据。
- 因随机设计考虑了患者偏好,试验还可分析患者偏好效应并比较随机与非随机样本,以提高研究结论的稳健性和外推性。
研究设计与样本
- 多中心、实用性、含患者偏好臂的随机对照试验。
- 计划从七个社区纳入400例原发性高血压患者。
- 社区先被随机分为两个研究集群,一个采用强制随机,另一个允许患者按偏好选择治疗。
- 强制随机集群中患者被随机分配接受热敏灸联合原降压方案(热敏灸组)或仅原降压方案(对照组),疗程6个月。
- 患者偏好集群中,有偏好的患者可选择接受热敏灸或对照,无偏好者则随机分配。
主要发现
- 主要结局为收缩压自基线的变化。
- 次要结局包括舒张压变化、降压药物剂量、生活质量、高血压症状严重程度及心血管事件发生率。
- 还将评估患者对热敏灸方案的依从性、成本效果比及安全性结局。
- 结局数据在6次每月访视时收集。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Low- and middle-income countries have a high prevalence of primary hypertension, but its treatment and control are often low. Heat-sensitive moxibustion (HSM), an innovative acupoint stimulation technique, may be effective for treating hypertension and thus used appropriately in primary healthcare. The objective of this study is to investigate whether HSM is effective and safe for the treatment of primary hypertension in the community. METHODS: This study is a multicenter, pragmatic, randomized controlled trial (RCT) with patient-preference arms. Four hundred patients with primary hypertension from seven communities will be enrolled. Initially, the communities will be randomly assigned into two study clusters, one using compulsory randomization and the other allowing treatment selection by patient preferences. Then, patients in the compulsory randomization cluster will be randomized to receive HSM plus their original antihypertensive regimen (HSM group) or only their original antihypertensive regimen (control group) for 6 months. Patients in the patient preference cluster may choose to receive HSM or control if they have a preference; otherwise, patients will be randomly assigned. The primary outcome is the change in systolic blood pressure from baseline; secondary outcomes include change in diastolic blood pressure, dosage of antihypertensive drugs, quality of life (QoL), severity of hypertensive symptoms, and incidence of cardiovascular events. Patient compliance with the HSM regimen, the cost-effectiveness ratio, and safety outcomes will also be evaluated. Outcome data will be collected at 6 monthly visits. DISCUSSION: This trial will provide important evidence regarding HSM as a technique for primary hypertension in primary healthcare settings. Given the randomization with patient preferences considered, the trial will also allow analyzing patient-preference effects and the comparison of randomized and nonrandomized samples, to improve the robustness and extrapolation of study conclusions. TRIAL REGISTRATION: ClinicalTrials.gov NCT04788563 . Registered on March 9, 2021.
引用
- Zhou X, Li S, Li L, et al. Community-based heat-sensitive moxibustion for primary hypertension: study protocol for a randomized controlled trial with patient-preference arms. Trials. 2022. PMID: 35172871. doi:10.1186/s13063-022-06092-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。